01Your map
See exactly what's changing
Sixteen clinically-derived markers measured from one selfie — midface volume, cheek hollowing, nasolabial folds, jawline softening, laxity. Each one scored and compared to your last scan.
Public launch on iOS soon
You lost the weight.
Don't lose your face.
A sixty-second selfie tells you exactly what's changing on your face — and what to do about it. Sixteen skin markers, a personalized routine with specific products, and a shortlist of procedures when products aren't enough. On Ozempic, Wegovy, Mounjaro, Zepbound, or compounded GLP-1. Your photo never leaves your device.
Coming toiPhone
First 500 get lifetime access
Cited research includes the Vanderbilt Facial Volume Study (2025), Journal of Cosmetic Dermatology 2026, and American Society for Dermatologic Surgery.
Your Volume Score
Week 127.2of 10+0.3
Midface volume
−9%Jawline definition
−3%Skin laxity
+2%Next: start GHK-Cu peptide + Rx tretinoin, reassess in 8 weeks.
What Revolume does
Three things. One selfie away.
02Your routine
Know exactly what to use
A personalized AM + PM routine. Specific products by name — copper peptide, retinoid, growth-factor serum, oral collagen. Matched to your markers, your stage, your budget.
03Your shortlist
Know when to go further
When products aren't enough, we hand you the procedure options that actually work — Sculptra, RF microneedling, HA filler — with honest cost ranges and board-certified providers near you.
The problem nobody warned you about
Because losing weight shouldn't cost you your face.
The clinical research is clear. GLP-1 medications strip subcutaneous fat from the face at the same rate they strip it from the body. Most patients don't see it coming. Nobody told them. Revolume is the first scan built to tell them — early, honestly, and privately.
of GLP-1 users experience facial volume loss
Dr. Amy Forman Taub, Advanced Dermatology
midface volume lost per 10 kg of weight loss
Vanderbilt Facial Volume Study, 2025
rise in “Ozempic face” searches since 2021
Journal of Cosmetic Dermatology, 2026
Everything the scan sees
Sixteen skin markers. Every one of them specific to you.
Most skin analysis apps score acne, redness, and fine lines. Revolume scores what actually changes on GLP-1 — midface volume, cheek hollowing, jawline softening — and tracks them across every scan you take.
Midface volume
Cheek hollowing
Jawline softening
Temple depression
Nasolabial folds
Marionette lines
Under-eye hollows
Jowl formation
Midface volume
Cheek hollowing
Jawline softening
Temple depression
Nasolabial folds
Marionette lines
Under-eye hollows
Jowl formation
Skin laxity
Pore visibility
Fine lines
Redness / erythema
Tone evenness
Sun damage
Collagen density
Snap-back index
Skin laxity
Pore visibility
Fine lines
Redness / erythema
Tone evenness
Sun damage
Collagen density
Snap-back index
How Revolume works
We've done the analysis. Your turn to decide.
One path if you want to understand what's happening. Another if you already know — and you want the shortlist of products, peptides, and procedures that actually work for post-GLP-1 skin.
Start here
Take the scan
One selfie. Natural light. Sixty seconds. Your image is processed entirely on-device — it never touches our servers.
Scanning · 10 of 16 markers
See the map
Your markers, ranked
Sixteen clinically-derived markers. Sorted by where you are on the GLP-1 timeline. Compared to every scan you've taken before.
Midface volume
-9%
Cheek hollowing
-7%
Nasolabial folds
-4%
Jawline softening
-3%
Skin laxity
-2%
Under-eye hollows
+1%
Tone evenness
+2%
Built on the research
Clinically-grounded. Consumer-shaped.
Revolume's skin markers are derived from peer-reviewed dermatology and plastic surgery literature specific to GLP-1 weight loss and facial change. Revolume does not provide medical advice.
Sources cited
- Journal of Cosmetic Dermatology, 2026↗
- Plastic & Reconstructive Surgery — Global Open, 2025↗
- American Society for Dermatologic Surgery↗
- Vanderbilt Facial Volume Study, 2025↗
Your photo never leaves your device.
The scan runs locally in your browser. We don't store images, sell data, or train on your face. Ever.
What people ask us first
Reserve your spot before the scan opens.
No. Revolume is a tracking and analysis tool, not a dermatologist. We help you see changes, understand them, and find the right professional when procedures make sense. For medical decisions, talk to your doctor or a board-certified dermatologist.
The scan runs on-device, in your browser. Your image is never uploaded, never stored on our servers, never sent to any third party, and never used to train a model.
Anyone on semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), or compounded GLP-1s who wants to understand the facial changes they're seeing — and do something about them.
Partially. Topicals support skin quality; volume itself is restored via biostimulators (Sculptra), fillers, or RF microneedling. The earlier you start a plan, the more you can prevent vs reverse.
Yes. All GLP-1 receptor agonists cause facial volume changes through the same mechanism — rapid subcutaneous fat loss. The markers we track apply across the drug class.
General skin apps score acne, redness, and fine lines. Revolume adds the markers specific to post-rapid-weight-loss skin — midface volume, jawline softening, facial deflation. It's the first scan built for this audience.
Early access · Free
First 500 onlyReserve lifetime access in advance
Free forever for the first five hundred. After launch the scan moves to a paid plan. Priority iOS invite included.
No spam. No resale of your data. Unsubscribe at any time. By joining you confirm you're 18+ and on a GLP-1 medication, or considering one.
Ready to see what's actually changing?
Join the early list. We'll email the moment Revolume opens the scan — and again when the iPhone app lands. No spam, no resale, easy to unsubscribe.
First 500 members · Lifetime access · Priority iOS invite
